This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

E. RICHARD HARRELL, M.D.; FLORANTE C. BOCOBO, M.D.; ARTHUR C. CURTIS, M.D.

AMA Arch Intern Med. 1954;93(1):162-164.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SPOROTRICHOSIS has been treated successfully with the iodides for many years. Nevertheless, there are occasional patients with this disease who are resistant to iodide therapy. The report of Elson¹ in 1945 showing that Propamidine, one of the aromatic diamidines, exhibits in vitro antifungal activity opened up an entirely new group of chemotherapeutic agents in the treatment of the deep mycotic infections. One of the members of this diamidine group, stilbamidine (4,4'-stilbenedicarboxyamidine), is now being used extensively in the treatment of North American blastomycosis* and has also been successfully used in actinomycosis.⁵ Since sporotrichosis has apparently never been treated with stilbamidine, it was decided to determine the in vivo effect of this fungicidal agent.

REPORT OF A CASE

W. E., an 18-year-old white male farmer, was referred to the dermatology department of the University Hospital on June 26, 1953, because of an ulcer of the distal end of the . . . [Full Text PDF of this Article]

Author Affiliations
ANN ARBOR, MICH.

From the Department of Dermatology and Syphilology, University of Michigan Hospital, Medical School, University of Michigan.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?